← All stocks

Turn Therapeutics Inc.

TTRX Net buying

CIK 0002023016 #3605 in the set updated 21 Sep 2026

Bought (12 mo)

$308.46K

out of their own pocket, the only kind of buying there is

Sold (12 mo)

$0.00

$0.00 on a plan · $0.00 straight out of an exercise

Sold at will

$0.00

0 of 0 sales

Net

+$308.46K

+$308.46K against sales at will

By person

8 insiders · 9 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

GOLDEN ARTHUR F

Director

$192.87K (3)

—

+$192.87K

360,602

1.21%

$1.26M

—

Chesed Abraham

Board Observer

$65.72K (1)

—

+$65.72K

1,447,268

4.86%

$5.07M

+1.0%

Chaudhary Zuraiz

See Remarks

$49.87K (5)

—

+$49.87K

12,500

0.0420%

$43.75K

—

Burnam Bradley Evan

Chief Executive Officer

—

300,000

1.01%

$1.05M

−50.0%

Dewhurst Martin William

Director

—

21,882

0.0735%

$76.59K

—

Gengos Andrew

Director

—

10,000

0.0336%

$35.00K

—

Kester Kent Edward

Director

—

10,000

0.0336%

$35.00K

—

Ghodadra Neilesh Shailesh

Chief Medical Officer

—

10,000

0.0336%

$35.00K

—

Individual transactions

Nothing of that kind in this period.

What was left out

Form 4 filings counted 23

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 3

Sales on a Rule 10b5-1 plan 0

Sales straight out of an exercise 0

Sales at will 0

Transactions with no price 0

Shares from compensation/vesting 1,861,882

History held since 10 Oct 2025